313 related articles for article (PubMed ID: 30107175)
1. Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.
Gopal RK; Kübler K; Calvo SE; Polak P; Livitz D; Rosebrock D; Sadow PM; Campbell B; Donovan SE; Amin S; Gigliotti BJ; Grabarek Z; Hess JM; Stewart C; Braunstein LZ; Arndt PF; Mordecai S; Shih AR; Chaves F; Zhan T; Lubitz CC; Kim J; Iafrate AJ; Wirth L; Parangi S; Leshchiner I; Daniels GH; Mootha VK; Dias-Santagata D; Getz G; McFadden DG
Cancer Cell; 2018 Aug; 34(2):242-255.e5. PubMed ID: 30107175
[TBL] [Abstract][Full Text] [Related]
2. Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.
Ganly I; Makarov V; Deraje S; Dong Y; Reznik E; Seshan V; Nanjangud G; Eng S; Bose P; Kuo F; Morris LGT; Landa I; Carrillo Albornoz PB; Riaz N; Nikiforov YE; Patel K; Umbricht C; Zeiger M; Kebebew E; Sherman E; Ghossein R; Fagin JA; Chan TA
Cancer Cell; 2018 Aug; 34(2):256-270.e5. PubMed ID: 30107176
[TBL] [Abstract][Full Text] [Related]
3. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
[TBL] [Abstract][Full Text] [Related]
4. Short Review: Genomic Alterations in Hürthle Cell Carcinoma.
Ganly I; McFadden DG
Thyroid; 2019 Apr; 29(4):471-479. PubMed ID: 30848171
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
6. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer.
Sohn SY; Park WY; Shin HT; Bae JS; Ki CS; Oh YL; Kim SW; Chung JH
Thyroid; 2016 May; 26(5):672-82. PubMed ID: 26971368
[TBL] [Abstract][Full Text] [Related]
7. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.
Tallini G; Hsueh A; Liu S; Garcia-Rostan G; Speicher MR; Ward DC
Lab Invest; 1999 May; 79(5):547-55. PubMed ID: 10334566
[TBL] [Abstract][Full Text] [Related]
8. Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma.
Ganly I; Liu EM; Kuo F; Makarov V; Dong Y; Park J; Gong Y; Gorelick AN; Knauf JA; Benedetti E; Tait-Mulder J; Morris LGT; Fagin JA; Intlekofer AM; Krumsiek J; Gammage PA; Ghossein R; Xu B; Chan TA; Reznik E
Sci Adv; 2022 Jun; 8(25):eabn9699. PubMed ID: 35731870
[TBL] [Abstract][Full Text] [Related]
9. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
Ganly I; Ricarte Filho J; Eng S; Ghossein R; Morris LG; Liang Y; Socci N; Kannan K; Mo Q; Fagin JA; Chan TA
J Clin Endocrinol Metab; 2013 May; 98(5):E962-72. PubMed ID: 23543667
[TBL] [Abstract][Full Text] [Related]
10. Near-haploidization significantly associates with oncocytic adrenocortical, thyroid, and parathyroid tumors but not with mitochondrial DNA mutations.
Corver WE; van Wezel T; Molenaar K; Schrumpf M; van den Akker B; van Eijk R; Ruano Neto D; Oosting J; Morreau H
Genes Chromosomes Cancer; 2014 Oct; 53(10):833-44. PubMed ID: 24909752
[TBL] [Abstract][Full Text] [Related]
11. Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.
Corver WE; Ruano D; Weijers K; den Hartog WC; van Nieuwenhuizen MP; de Miranda N; van Eijk R; Middeldorp A; Jordanova ES; Oosting J; Kapiteijn E; Hovens G; Smit J; van Wezel T; Morreau H
PLoS One; 2012; 7(6):e38287. PubMed ID: 22675538
[TBL] [Abstract][Full Text] [Related]
12. Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.
Xu B; Reznik E; Tuttle RM; Knauf J; Fagin JA; Katabi N; Dogan S; Aleynick N; Seshan V; Middha S; Enepekides D; Casadei GP; Solaroli E; Tallini G; Ghossein R; Ganly I
Endocrine; 2019 Apr; 64(1):97-108. PubMed ID: 30689169
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
[TBL] [Abstract][Full Text] [Related]
14. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.
Gasparre G; Porcelli AM; Bonora E; Pennisi LF; Toller M; Iommarini L; Ghelli A; Moretti M; Betts CM; Martinelli GN; Ceroni AR; Curcio F; Carelli V; Rugolo M; Tallini G; Romeo G
Proc Natl Acad Sci U S A; 2007 May; 104(21):9001-6. PubMed ID: 17517629
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization.
Erickson LA; Jalal SM; Goellner JR; Law ME; Harwood A; Jin L; Roche PC; Lloyd RV
Am J Surg Pathol; 2001 Jul; 25(7):911-7. PubMed ID: 11420462
[TBL] [Abstract][Full Text] [Related]
16. Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer.
Masoodi T; Siraj AK; Siraj S; Azam S; Qadri Z; Albalawy WN; Parvathareddy SK; Al-Sobhi SS; Al-Dayel F; Alkuraya FS; Al-Kuraya KS
Thyroid; 2020 Jan; 30(1):42-56. PubMed ID: 31668133
[No Abstract] [Full Text] [Related]
17. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
[TBL] [Abstract][Full Text] [Related]
19. Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.
Paulsson JO; Rafati N; DiLorenzo S; Chen Y; Haglund F; Zedenius J; Juhlin CC
J Clin Endocrinol Metab; 2021 Oct; 106(11):3265-3282. PubMed ID: 34171097
[TBL] [Abstract][Full Text] [Related]
20. TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.
Melo M; Gaspar da Rocha A; Batista R; Vinagre J; Martins MJ; Costa G; Ribeiro C; Carrilho F; Leite V; Lobo C; Cameselle-Teijeiro JM; Cavadas B; Pereira L; Sobrinho-Simões M; Soares P
J Clin Endocrinol Metab; 2017 Jun; 102(6):1898-1907. PubMed ID: 28323937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
